Biosig Technologies, Common Stock Analysis
| BSGM Stock | USD 1.30 0.02 1.56% |
BioSig Technologies, Common is overvalued with Real Value of 1.05 and Hype Value of 1.3. The main objective of BioSig Technologies, otc analysis is to determine its intrinsic value, which is an estimate of what BioSig Technologies, Common is worth, separate from its market price. There are two main types of BioSig Technologies,'s stock analysis: fundamental analysis and technical analysis.
The BioSig Technologies, otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
BioSig |
BioSig OTC Stock Analysis Notes
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.86. BioSig Technologies, last dividend was issued on the 11th of September 2018. The entity had 1:10 split on the 2nd of February 2024. BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.The quote for BioSig Technologies, Common is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on BioSig Technologies, Common please contact Kenneth MBA at 203 409 5444 or go to https://www.biosig.com.BioSig Technologies, Investment Alerts
| BioSig Technologies, is way too risky over 90 days horizon | |
| BioSig Technologies, may become a speculative penny stock | |
| BioSig Technologies, appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 18 K. Net Loss for the year was (28.69 M) with profit before overhead, payroll, taxes, and interest of 242 K. | |
| BioSig Technologies, Common currently holds about 887 K in cash with (17.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 18.0% of the company shares are held by company insiders |
BioSig Technologies, Upcoming and Recent Events
Earnings reports are used by BioSig Technologies, to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 30th of September 2023 Last Quarter Report | View |
BioSig Technologies, Thematic Classifications
In addition to having BioSig Technologies, otc stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Health ManagementHealthcare providers, hospitals |
BioSig Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioSig Technologies,'s market, we take the total number of its shares issued and multiply it by BioSig Technologies,'s current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 21st of December, BioSig Technologies, shows the Downside Deviation of 11.68, mean deviation of 9.44, and Risk Adjusted Performance of 0.1784. BioSig Technologies, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for BioSig Technologies, Common, which can be compared to its peers. Please confirm BioSig Technologies, jensen alpha, as well as the relationship between the potential upside and skewness to decide if BioSig Technologies, is priced correctly, providing market reflects its regular price of 1.3 per share. Given that BioSig Technologies, is a hitting penny stock territory we recommend to closely look at its total risk alpha.BioSig Technologies, Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioSig Technologies, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioSig Technologies,. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioSig Technologies, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioSig Technologies, insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioSig Technologies,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BioSig Technologies, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BioSig Technologies, Outstanding Bonds
BioSig Technologies, issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioSig Technologies, uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioSig bonds can be classified according to their maturity, which is the date when BioSig Technologies, Common has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
BioSig Technologies, Predictive Daily Indicators
BioSig Technologies, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioSig Technologies, otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BioSig Technologies, Forecast Models
BioSig Technologies,'s time-series forecasting models are one of many BioSig Technologies,'s otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioSig Technologies,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioSig OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how BioSig Technologies, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioSig shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as BioSig Technologies,. By using and applying BioSig OTC Stock analysis, traders can create a robust methodology for identifying BioSig entry and exit points for their positions.
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding BioSig Technologies, to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Other Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.